The NBR Rich List
6 mins to read
Featured Rich Lister: Karl Ye
In the 2024 financial year, the NZ subsidiary of Karl Ye-owned GMP Pharmaceuticals boosted revenue by 36% to $51m and declared an after-tax profit of $4.7m.
Owen Poland
Wed, 10 Sep 2025